Home Health News Pfizer and BioNTech to offer COVID vaccine to volunteers who got placebo – KSL.com

Pfizer and BioNTech to offer COVID vaccine to volunteers who got placebo – KSL.com

2 min read
0
3

WASHINGTON (Reuters) — Pfizer and its partner BioNTech plan to give volunteers who received a placebo in its COVID-19 vaccine trial an option to receive a first dose of the vaccine by March 1, 2021, while staying within the study.

The trial’s Vaccine Transition Option allows all participants aged 16 or older the choice to discover whether they were given the placebo, “and for participants who learn they received the placebo, to have the option to receive the investigational vaccine while staying in the study,” the companies said on their website for trial participants.

The U.S. Food and Drug Administration and a panel of its outside advisers have expressed concerns over Pfizer’s “unblinding” plan, saying it could make it harder to continue collecting data on safety and effectiveness needed to win full FDA approval of the vaccine.

Trial participants who received the placebo will have two doses of the investigational vaccine reserved for them within the study, the companies said on the website.

“The study doctor will follow the latest guidance from the U.S. Centers for Disease Control and Prevention and their local health authorities to offer the Vaccine Transition Option to participants in a prioritized manner,” the companies said.

(Reporting by Aakriti Bhalla in Bengaluru; Editing by Daniel Wallis)

Related Stories

Aakriti Bhalla

More stories you may be interested in

Let’s block ads! (Why?)


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

With obesity on the rise, the best diet may be tailored to our genes, experts say – ABC News

With the COVID-19 pandemic drawing more attention to America’s obesity problem, a gr…